https://www.prnewswire.com/news-releases/dxterity-receives-new-york-authorization-for-type-1-interferon-ifn-1-gene-signature-testing-for-systemic-lupus-erythematosus-patients-301625857.html
DxTerity Receives New York Authorization for Type 1 Interferon (IFN-1) Gene Signature Testing for...
/PRNewswire/ -- The DxTerity IFN-1 gene signature test is for patients with Systemic Lupus Erythematosus (SLE or lupus), a chronic autoimmune disease...
type 1 interferon